Racial minorities are under-represented in SLE clinical trials: A systematic review and meta-analysis

BACKGROUND: With numerous emerging treatments for systemic lupus erythematosus (SLE), it is imperative that clinical trials include diverse populations reflective of those with SLE, especially active disease. Epidemiological data from North America and Europe indicate that the p…

Criar conta gratuita para acessar o conteúdo completo